Targeting Novel Sodium Iodide Symporter Interactors ADP-Ribosylation Factor 4 and Valosin-Containing Protein Enhances Radioiodine Uptake.


Journal

Cancer research
ISSN: 1538-7445
Titre abrégé: Cancer Res
Pays: United States
ID NLM: 2984705R

Informations de publication

Date de publication:
01 01 2020
Historique:
received: 26 06 2019
revised: 17 09 2019
accepted: 25 10 2019
pubmed: 2 11 2019
medline: 20 6 2020
entrez: 2 11 2019
Statut: ppublish

Résumé

The sodium iodide symporter (NIS) is required for iodide uptake, which facilitates thyroid hormone biosynthesis. NIS has been exploited for over 75 years in ablative radioiodine (RAI) treatment of thyroid cancer, where its ability to transport radioisotopes depends on its localization to the plasma membrane. The advent of NIS-based

Identifiants

pubmed: 31672844
pii: 0008-5472.CAN-19-1957
doi: 10.1158/0008-5472.CAN-19-1957
pmc: PMC7470018
mid: NIHMS1612640
doi:

Substances chimiques

Iodine Radioisotopes 0
Symporters 0
sodium-iodide symporter 4XE5NDT4K1
VCP protein, human EC 3.6.4.6
Valosin Containing Protein EC 3.6.4.6
ADP-Ribosylation Factors EC 3.6.5.2
ARF4 protein, human EC 3.6.5.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

102-115

Subventions

Organisme : NCI NIH HHS
ID : R01 CA072597
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA050706
Pays : United States
Organisme : Medical Research Council
ID : MR/J001414/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P000509/1
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : RG_05-052
Pays : United Kingdom
Organisme : Cancer Research UK
Pays : United Kingdom

Informations de copyright

©2019 American Association for Cancer Research.

Références

Life Sci. 2012 Aug 21;91(3-4):137-42
pubmed: 22771697
Thyroid. 2011 Nov;21(11):1217-25
pubmed: 22007921
J Clin Endocrinol Metab. 2019 May 1;104(5):1417-1428
pubmed: 30256977
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W169-75
pubmed: 17576678
J Clin Endocrinol Metab. 2001 Jun;86(6):2697-700
pubmed: 11397873
J Cell Sci. 2009 Sep 15;122(Pt 18):3393-402
pubmed: 19706688
J Clin Endocrinol Metab. 2001 Jul;86(7):3327-35
pubmed: 11443208
Liver Transpl. 2015 Apr;21(4):442-53
pubmed: 25482651
Trends Biochem Sci. 2001 Aug;26(8):490-6
pubmed: 11504625
J Endocrinol. 1999 Dec;163(3):495-504
pubmed: 10588823
Cell. 2014 Oct 23;159(3):676-90
pubmed: 25417114
Lancet Diabetes Endocrinol. 2014 May;2(5):356-8
pubmed: 24795243
Nature. 2001 Dec 6;414(6864):652-6
pubmed: 11740563
Eur J Endocrinol. 2009 Dec;161(6):923-31
pubmed: 19773371
Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2264-9
pubmed: 21262816
Int J Cancer. 2015 May 1;136(9):2187-95
pubmed: 25284703
Endocr Relat Cancer. 2006 Mar;13(1):257-69
pubmed: 16601293
J Clin Invest. 2016 Mar 1;126(3):1052-66
pubmed: 26878173
J Clin Endocrinol Metab. 2013 Jul;98(7):2876-86
pubmed: 23678037
Clin Cancer Res. 2015 Mar 1;21(5):1028-35
pubmed: 25549723
J Endocrinol. 2008 Nov;199(2):243-52
pubmed: 18762555
Biochem Biophys Res Commun. 2015 Jul 31;463(3):453-7
pubmed: 26043696
Lancet Diabetes Endocrinol. 2014 Oct;2(10):830-42
pubmed: 24898835
Sci Rep. 2017 Mar 21;7:44912
pubmed: 28322292
J Clin Endocrinol Metab. 2001 Jul;86(7):3430-5
pubmed: 11443220
J Endocrinol. 2000 Oct;167(1):125-35
pubmed: 11018760
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4834-9
pubmed: 21383145
Obstet Gynecol. 1974 Sep;44(3):398-402
pubmed: 4852305
Int J Cancer. 2014 Aug 1;135(3):598-610
pubmed: 24382797
J Clin Invest. 2016 Nov 1;126(11):4119-4124
pubmed: 27669459
Nucl Med Biol. 2001 Oct;28(7):829-34
pubmed: 11578905
Nat Med. 2000 Aug;6(8):871-8
pubmed: 10932223
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Mol Cell Biochem. 2006 Sep;289(1-2):65-72
pubmed: 16718378
Eur J Endocrinol. 2006 Oct;155(4):495-512
pubmed: 16990649
Curr Med Chem. 2018;25(19):2260-2271
pubmed: 29345574
Cancer Res. 2009 Nov 1;69(21):8317-25
pubmed: 19861538
Gene Ther. 2019 Apr;26(3-4):93-108
pubmed: 30683895
Molecules. 2015 Feb 12;20(2):3027-49
pubmed: 25685910
J Cell Sci. 2017 Dec 1;130(23):3975-3987
pubmed: 29025970
N Engl J Med. 2015 Feb 12;372(7):621-30
pubmed: 25671254
Annu Rev Physiol. 2017 Feb 10;79:261-289
pubmed: 28192058
J Biol Chem. 2008 Mar 21;283(12):7445-54
pubmed: 18199748
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
J Clin Oncol. 2009 Nov 10;27(32):5410-7
pubmed: 19826128
J Nucl Med. 2015 Apr;56(4):600-6
pubmed: 25745085
Genome Biol. 2007;8(9):R183
pubmed: 17784955
Nature. 1996 Feb 1;379(6564):458-60
pubmed: 8559252
Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3301-6
pubmed: 15728366
Nat Chem Biol. 2013 Sep;9(9):548-56
pubmed: 23892893
Thyroid Res. 2018 Oct 11;11:13
pubmed: 30337961
Cancer Res. 2004 Jan 1;64(1):415-22
pubmed: 14729653
Mol Oncol. 2016 Dec;10(10):1559-1574
pubmed: 27729194
Surgery. 2006 Dec;140(6):960-6; discussion 966-7
pubmed: 17188145
AAPS J. 2018 Aug 27;20(6):94
pubmed: 30151644

Auteurs

Alice Fletcher (A)

Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.

Martin L Read (ML)

Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.

Caitlin E M Thornton (CEM)

Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.

Dean P Larner (DP)

Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.

Vikki L Poole (VL)

Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.

Katie Brookes (K)

Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.

Hannah R Nieto (HR)

Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.

Mohammed Alshahrani (M)

Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.

Rebecca J Thompson (RJ)

Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.

Gareth G Lavery (GG)

Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.

Iñigo Landa (I)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.

James A Fagin (JA)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

Moray J Campbell (MJ)

Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio.

Kristien Boelaert (K)

Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.

Andrew S Turnell (AS)

Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.

Vicki E Smith (VE)

Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.

Christopher J McCabe (CJ)

Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom. mccabcjz@bham.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH